Three startups have recently announced successful funding rounds. Augmental Technologies, after nearly five years of development, secured a $4 million seed round led by SCI Ventures, with participation from Murata, Revere Partners, LivEdge Capital, Fen Ventures, CaraoVC, and Tesserakt Ventures. Move AI raised $1.4 million in a pre-seed round led by E14 Fund, with support from Pioneer Fund, Taro Fund, and ten angel investors, including Y Combinator founders. Dash Bio, co-founded by Moderna's former Chief Data & AI Officer Dave Johnson and Ander Tallett, raised $6.5 million in a seed round led by Swift Ventures and Freestyle VC. Dash Bio specializes in bioanalysis from in vivo through clinical studies and is based in Newton, MA.
Thrilled to announce we are leading the $6.5M seed round for Dash Bio - a new robotics startup helping to get miracle drugs to market cheaper and faster! 🧪💊https://t.co/2qLODJf74O
Moderna Alums Launch Biotech-Services Startup Dash Bio #DisruptiveTech https://t.co/EgGwvnns4M
Some of Dash Bio's seed investors incl Swift Ventures/@bjwilson34, @freestylevc/@mariabrw & LifeX Ventures. Their robotics & clinical bioanalysis lab is in Newton, MA. They are also able to work w/CROs 1/n https://t.co/1imHeWj893